News
Media
Peer ExchangeCase-Based Psych PerspectivesClinical Case CollectiveInsightsPeers & PerspectivesSlideshowsVideos
Conferences
Conference CoverageConference Listing
Publication
Psychiatric Times
More
Job Board
CME/CE
Partners
Editorial
Resources
Between the LinesExpert PerspectivesClinical ConsultClinical ScalesInteractive ToolsPartner PerspectivesQ&AQuizzesSeriesSpecial ReportsSponsored

Subscribe

  • News
  • Media
  • Conferences
  • Publication
  • Job Board
  • CME/CE
  • Partners
  • Editorial
  • Resources
  • Subscribe
  • ADHD
  • Addiction & Substance Use
    • Gambling
    • Opioid Related Disorders
    • Alcohol Abuse
    • Amphetamine Related Disorders
    • Substance Use Disorder
  • Alzheimer Disease
  • Anxiety & Stress Disorders
    • Disaster Psychiatry
    • Panic Disorder
    • Trauma And Violence
    • Traumatic Stress Disorders
  • Bipolar Disorder
    • Mania
  • COVID-19
  • Cannabis
  • Case Discussions
  • Child & Adolescent Psychiatry
  • Climate Change
  • Comorbidity
  • Compulsive Disorders
  • Cultural Psychiatry
  • Digital Therapeutics
  • Diversity, Equity, Inclusion
  • Drug Watch
  • Eating Disorders
  • Emergency Psychiatry
  • Ethics
  • Forensic Psychiatry
    • Munchausen Syndrome
    • Sexual Offenses
  • Geriatric Psychiatry
  • Integrative Psychiatry
  • Major Depressive Disorder
  • Media & Psychiatry
  • Mental Health Awareness Month
  • Mood Disorders
  • Neuropsychiatry
    • Cognitive Disorders
    • Dementia
    • Autism
  • PTSD
  • Personality Disorders
    • Compulsive Personality Disorder
    • Dependent Personality Disorder
    • Dissociative Identity Disorder
    • Histrionic Personality Disorder
    • Schizoid Personality Disorder
    • Antisocial Personality Disorder
    • Borderline Personality
  • Postpartum Depression
  • Psychedelics
  • Psychopharmacology
  • Psychosomatics
    • Delirium
    • Metabolic Disorders
    • Somatoform Disorder
  • Psychotherapy
    • Cognitive Behavioral Therapy
  • Schizophrenia/Psychosis
    • Paranoid Schizophrenia
    • Psychotic Affective Disorders
    • Schizoaffective
    • Schizophrenia Psychotic Features
    • Schizotypal Personality Disorder
    • Catatonic Schizophrenia
  • Sleep Disorders
    • Nocturnal Paroxysmal Dystonia
    • Sleep Deprivation
    • Sleep Wake Transition
    • Circadian Rhythm Sleep Disorders
  • Special Populations
    • Pervasive Developmental Disorder
    • Gender Issues
    • Military Mental Health
  • Sports Psychiatry
  • Suicide
  • Tardive Dyskinesia
  • Technology & Psychiatry
  • Transcranial Magnetic Stimulation
Spotlight -
Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|
Major Depressive Disorder
Advertisement

Helena B. Hansen, MD, PhD

Advertisement

Dr Hansen is Professor of Anthropology and Psychiatry, and Research Chair in the Social Medicine Theme, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Articles by Helena B. Hansen, MD, PhD

opioid crisis

Harnessing Harm-Reduction Methods to Combat the Opioid Crisis

ByNazanin Izadi, HBSc,Anees Bahji, MD, FRCPC,Nitin Chopra, MD,Sara Ling, RN, PhD,Helena B. Hansen, MD, PhD,Tony P. George, MD, FRCPC
September 14th 2021

Lessons from Novel Harm Reduction Methods

ByNazanin Izadi, HBSc,Anees Bahji, MD, FRCPC,Nitin Chopra, MD,Sara Ling, RN, PhD,Helena B. Hansen, MD, PhD,Tony P. George, MD, FRCPC
June 1st 2021

How can understanding the opioid crisis in Canada inform strategies in the United States?

Advertisement

Latest Updated Articles

  • Lessons from Novel Harm Reduction Methods
    Lessons from Novel Harm Reduction Methods

    Published: June 1st 2021 | Updated:



Advertisement
Advertisement

Trending on Psychiatric Times

1

Asynchronous ADHD Assessment: New Tools for Better Evaluation

2

Women Are Diagnosed With ADHD 5 Years Later Than Men

3

Seltorexant Well-Tolerated in Adolescents as an Adjunct Treatment for Major Depressive Disorder

4

New Data on Lumateperone for Prevention of Relapse in Schizophrenia

5

Phase 3 Data Support CT-155 as a Novel Digital Therapeutic for Negative Symptoms in Schizophrenia at ECNP

  • About
  • Advertise
  • Contact Us
  • Editorial
  • Terms and Conditions
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us